BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21280010)

  • 1. DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigen.
    Mor-Vaknin N; Kappes F; Dick AE; Legendre M; Damoc C; Teitz-Tennenbaum S; Kwok R; Ferrando-May E; Adams BS; Markovitz DM
    Arthritis Rheum; 2011 Feb; 63(2):556-67. PubMed ID: 21280010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti-Tumor Necrosis Factor Therapy.
    Mor-Vaknin N; Rivas M; Legendre M; Mohan S; Yuanfan Y; Mau T; Johnson A; Huang B; Zhao L; Kimura Y; Spalding SJ; Morris PW; Gottlieb BS; Onel K; Olson JC; Edelheit BS; Shishov M; Jung LK; Cassidy EA; Prahalad S; Passo MH; Beukelman T; Mehta J; Giannini EH; Adams BS; Lovell DJ; Markovitz DM
    Arthritis Rheumatol; 2018 Apr; 70(4):594-605. PubMed ID: 29287303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress.
    Kappes F; Fahrer J; Khodadoust MS; Tabbert A; Strasser C; Mor-Vaknin N; Moreno-Villanueva M; Bürkle A; Markovitz DM; Ferrando-May E
    Mol Cell Biol; 2008 May; 28(10):3245-57. PubMed ID: 18332104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DEK nuclear autoantigen is a secreted chemotactic factor.
    Mor-Vaknin N; Punturieri A; Sitwala K; Faulkner N; Legendre M; Khodadoust MS; Kappes F; Ruth JH; Koch A; Glass D; Petruzzelli L; Adams BS; Markovitz DM
    Mol Cell Biol; 2006 Dec; 26(24):9484-96. PubMed ID: 17030615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis.
    Mor-Vaknin N; Saha A; Legendre M; Carmona-Rivera C; Amin MA; Rabquer BJ; Gonzales-Hernandez MJ; Jorns J; Mohan S; Yalavarthi S; Pai DA; Angevine K; Almburg SJ; Knight JS; Adams BS; Koch AE; Fox DA; Engelke DR; Kaplan MJ; Markovitz DM
    Nat Commun; 2017 Feb; 8():14252. PubMed ID: 28165452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Juvenile arthritis, HLA-A2 and binding of DEK oncogene-peptides.
    Forero L; Zwirner NW; Fink CW; Fernández-Viña MA; Stastny P
    Hum Immunol; 1998 Jul; 59(7):443-50. PubMed ID: 9684994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to DEK oncoprotein in human inflammatory disease.
    Dong X; Wang J; Kabir FN; Shaw M; Reed AM; Stein L; Andrade LE; Trevisani VF; Miller ML; Fujii T; Akizuki M; Pachman LM; Satoh M; Reeves WH
    Arthritis Rheum; 2000 Jan; 43(1):85-93. PubMed ID: 10643703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to the 45 kDa DEK nuclear antigen in pauciarticular onset juvenile rheumatoid arthritis and iridocyclitis: selective association with MHC gene.
    Murray KJ; Szer W; Grom AA; Donnelly P; Levinson JE; Giannini EH; Glass DN; Szer IS
    J Rheumatol; 1997 Mar; 24(3):560-7. PubMed ID: 9058666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies to DEK oncoprotein in systemic lupus erythematosus (SLE).
    Wichmann I; Respaldiza N; Garcia-Lozano JR; Montes M; Sanchez-Roman J; Nuñez-Roldan A
    Clin Exp Immunol; 2000 Mar; 119(3):530-2. PubMed ID: 10691927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DEK, an autoantigen involved in a chromosomal translocation in acute myelogenous leukemia, binds to the HIV-2 enhancer.
    Fu GK; Grosveld G; Markovitz DM
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1811-5. PubMed ID: 9050861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The putative oncoprotein DEK, part of a chimera protein associated with acute myeloid leukaemia, is an autoantigen in juvenile rheumatoid arthritis.
    Sierakowska H; Williams KR; Szer IS; Szer W
    Clin Exp Immunol; 1993 Dec; 94(3):435-9. PubMed ID: 8252804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synovial fluid proteins differentiate between the subtypes of juvenile idiopathic arthritis.
    Rosenkranz ME; Wilson DC; Marinov AD; Decewicz A; Grof-Tisza P; Kirchner D; Giles B; Reynolds PR; Liebman MN; Kolli VS; Thompson SD; Hirsch R
    Arthritis Rheum; 2010 Jun; 62(6):1813-23. PubMed ID: 20222116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxic synovial environment and expression of macrophage inflammatory protein 3gamma/CCL20 in juvenile idiopathic arthritis.
    Bosco MC; Delfino S; Ferlito F; Battaglia F; Puppo M; Gregorio A; Gambini C; Gattorno M; Martini A; Varesio L
    Arthritis Rheum; 2008 Jun; 58(6):1833-8. PubMed ID: 18512817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating and synovial antibody profiling of juvenile arthritis patients by nucleic acid programmable protein arrays.
    Gibson DS; Qiu J; Mendoza EA; Barker K; Rooney ME; LaBaer J
    Arthritis Res Ther; 2012 Apr; 14(2):R77. PubMed ID: 22510425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoblastogenesis from synovial fluid-derived cells is related to the type and severity of juvenile idiopathic arthritis.
    Lazić E; Jelušić M; Grčević D; Marušić A; Kovačić N
    Arthritis Res Ther; 2012 Jun; 14(3):R139. PubMed ID: 22687048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Th17 transcription factor RORC2 is inversely correlated with FOXP3 expression in the joints of children with juvenile idiopathic arthritis.
    Olivito B; Simonini G; Ciullini S; Moriondo M; Betti L; Gambineri E; Cantarini L; De Martino M; Azzari C; Cimaz R
    J Rheumatol; 2009 Sep; 36(9):2017-24. PubMed ID: 19648312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synovial Fluid Neutrophils From Patients With Juvenile Idiopathic Arthritis Display a Hyperactivated Phenotype.
    Metzemaekers M; Malengier-Devlies B; Yu K; Vandendriessche S; Yserbyt J; Matthys P; De Somer L; Wouters C; Proost P
    Arthritis Rheumatol; 2021 May; 73(5):875-884. PubMed ID: 33264510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel autoantibody to the putative oncoprotein DEK in pauciarticular onset juvenile rheumatoid arthritis.
    Szer IS; Sierakowska H; Szer W
    J Rheumatol; 1994 Nov; 21(11):2136-42. PubMed ID: 7869324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies to DEK oncoprotein in a patient with systemic lupus erythematosus and sarcoidosis.
    Dong X; Michelis MA; Wang J; Bose R; DeLange T; Reeves WH
    Arthritis Rheum; 1998 Aug; 41(8):1505-10. PubMed ID: 9704652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intercellular trafficking of the nuclear oncoprotein DEK.
    Saha AK; Kappes F; Mundade A; Deutzmann A; Rosmarin DM; Legendre M; Chatain N; Al-Obaidi Z; Adams BS; Ploegh HL; Ferrando-May E; Mor-Vaknin N; Markovitz DM
    Proc Natl Acad Sci U S A; 2013 Apr; 110(17):6847-52. PubMed ID: 23569252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.